PFE

OIB Trade Alert: PFE

Pfizer (PFE) has run up over the past two weeks and our call is in the money. In addition to money rotating into pharmaceutical stocks recently, this week, a judge ruled that potential plaintiffs didn’t have standing to bring a class-action lawsuit against the company for allegedly steering patients toward high-priced drugs. Let’s roll our…

View details

OIB Trade Alert: BAC, PFE

I am recommending we sell calls on our uncovered shares of Bank of America (BAC) and Pfizer (PFE) to generate income and reduce our cost basis on the positions. Shares of Bank of America got whacked with the rest of the financial sector following the collapse of Silicon Valley Bank, Silvergate and Signature Bank, despite…

View details

OIB Trade Alert: BAC, PFE

Bank of America (BAC) and Pfizer (PFE) — two of our core positions – have sold off with the broader market over the past two weeks, down around 10% and 5%, respectively. BAC’s sell-off has been exacerbated by the decline in the financial sector following the collapse of Silicon Valley Bank. While California regulators have…

View details

OIB Trade Alert: BAC, PFE

I am recommending we roll our Bank of America (BAC) and Pfizer (PFE) puts out two weeks to generate more income and reduce our net debits on the positions. BAC Feb Week Four (2/24) 35.50 Put Current Stock Price: $33.92 Net Debit: $9.27 Action: Buy to close the BAC Feb Week Four (2/24) 35.50 Put for…

View details

OIB Trade Alert: GM, PFE

We temporarily exited our General Motors (GM) and Pfizer (PFE) positions ahead of the companies’ earnings announcements to avoid any unnecessary risk. GM shot up after reporting better-than-expected Q4 revenue and earnings and record profits for the full year. Moreover, management issued upbeat guidance for 2023 and announced it is buying a $650 million stake…

View details